Supernus Pharmaceuticals Inc (SUPN)
Total Liabilities
$396.88M
Quarterly · Period ending: · USD
SUPN Total Liabilities
Latest reported$396.88Mperiod ending
Latest reported$396.88Mperiod ending
SUPN Quarterly Total Liabilities ($86.06M → $396.88M)
Quarterly total liabilities
High-resolution chart · PNG
SUPN total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 396,883,000 | |
| 423,920,000 | |
| 390,934,000 | |
| 370,087,000 | |
| 318,505,000 | |
| 316,585,000 | |
| 332,340,000 | |
| 335,551,000 | |
| 358,375,000 | |
| 374,924,000 | |
| 356,157,000 | |
| 372,969,000 | |
| 373,191,000 | |
| 879,658,000 | |
| 816,304,000 | |
| 840,331,000 | |
| 853,539,000 | |
| 811,071,000 | |
| 873,301,000 | |
| 744,572,000 | |
| 787,481,000 | |
| 752,999,000 | |
| 759,244,000 | |
| 801,143,000 | |
| 825,046,000 | |
| 576,483,000 | |
| 564,854,000 | |
| 549,652,000 | |
| 540,771,000 | |
| 545,430,000 | |
| 524,788,000 | |
| 500,576,000 | |
| 462,307,000 | |
| 473,291,000 | |
| 156,984,000 | |
| 133,815,000 | |
| 116,973,000 | |
| 116,192,000 | |
| 117,813,000 | |
| 111,745,000 | |
| 77,611,000 | |
| 66,335,000 | |
| 69,855,000 | |
| 57,334,000 | |
| 51,803,000 | |
| 45,053,000 | |
| 66,154,000 | |
| 60,206,000 | |
| 60,821,000 | |
| 68,507,000 | |
| 77,531,000 | |
| 111,312,000 | |
| 96,081,000 | |
| 37,789,000 | |
| 36,419,000 | |
| 42,383,000 | |
| 41,985,000 | |
| 42,928,000 | |
| 44,287,000 | |
| 104,825,000 | |
| 91,329,000 | |
| 93,419,031 | |
| 86,055,000 |